NORDIC MEDICAL SOLUTIONS ApS: Financial statements 2017
CVR: 34352542
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
NORDIC MEDICAL SOLUTIONS ApS (CVR 34352542) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 24,578,759 and a net result of DKK 15,258,262 compared with DKK 15,251,087 the year before. That is an increase of 6.2% compared with the year before. Equity in the 2017 report amounted to DKK 17,259,349. The solvency ratio was 64.7%.
- Gross Profit
- DKK 24,578,759
- Profit/Loss
- DKK 15,258,262
- Equity
- DKK 17,259,349
- Total Assets
- DKK 26,658,725
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 24.6M | 15.3M | 17.3M | - |
| 2016 | - | 23.1M | 15.3M | 16.8M | - |
| 2015 | - | 17.7M | 11.3M | 12M | - |
| 2014 | - | 8M | 3.3M | 2.5M | - |
| 2013 | - | 5.5M | 1M | 1.5M | - |
Official annual report
Keep an eye on NORDIC MEDICAL SOLUTIONS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 6, 2017, Monica Reib has joined the board of directors of NORDIC MEDICAL SOLUTIONS ApS.
As of October 6, 2017, Carsten Gunnar Olesen has left the board of directors of NORDIC MEDICAL SOLUTIONS ApS.
As of July 1, 2017, Carsten Gunnar Olesen has stepped down as director of NORDIC MEDICAL SOLUTIONS ApS.
As of May 31, 2017, Casper Henrique Tingkær is registered as adm. dir. of NORDIC MEDICAL SOLUTIONS ApS.
As of May 31, 2017, Carsten Gunnar Olesen is registered as director of NORDIC MEDICAL SOLUTIONS ApS.
As of May 30, 2017, Casper Henrique Tingkær has stepped down as director of NORDIC MEDICAL SOLUTIONS ApS.
About NORDIC MEDICAL SOLUTIONS ApS
NORDIC MEDICAL SOLUTIONS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NORDIC PHARMA SOLUTIONS ApS. The management consists of Pernille Wandrup Rex. The board consists of Kim Erik Ginnerup (chair), Monica Reib, Pernille Wandrup Rex and Philip Fischer Stavnstrup. The company is owned by NMS Group A/S. The company has 16 employees (2026). In 2026, the company reported a gross profit of DKK 56,510,150 and a net result of DKK 31,681,814 compared with DKK 28,614,955 the year before. Equity in the 2026 report amounted to DKK 40,681,814.
